Auregen BioTherapeutics Overview

Life ScienceCompany

Is Auregen BioTherapeutics PE-backed?

Yes. Auregen BioTherapeutics is owned by private equity investor Gurnet Point Capital.

Where is Auregen BioTherapeutics headquartered?

Auregen BioTherapeutics is headquartered in Cambridge, Massachusetts.

What sector is Auregen BioTherapeutics in?

Auregen BioTherapeutics is a life science company.

Auregen BioTherapeutics

Auregen BioTherapeutics, Inc.

55 Cambridge Parkway,
Cambridge, Massachusetts 02142
United States,
www.auregen.bio

Auregen BioTherapeutics is a biotechnology company translating pioneering 3D bioprinting technology for innovative treatments for patients with rare disorders. Auregen BioTherapeutics is based in Cambridge, Massachusetts.



Try Mergr Free — See This and 220,677+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.